Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Myofibroma × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 2 Prostatic Neoplasms 1 Myofibroma 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Leiomyoma 1 Insulin Resistance 1 Endometriosis 1 Dementia 1 Cognitive Dysfunction 1 Alzheimer Disease 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03156127 2017-08-10

A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet

Boryung Pharmaceutical Co., Ltd

Phase 1 Withdrawn

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡